tiprankstipranks
Advertisement
Advertisement

ALKS Stock Latest News

Alkermes price target raised to $63 from $45 at Stifel
The FlyAlkermes price target raised to $63 from $45 at Stifel
15h ago
LLY
ALKS
American Express, Biogen upgraded: Wall Street’s top analyst calls
PremiumThe Fly
American Express, Biogen upgraded: Wall Street’s top analyst calls
8d ago
AXP
BBY
Thome Reiterates Buy on Encouraging Alixorexton Data and Reduced Oxybate Competition, Lifting Price Target to $57
PremiumRatings
Thome Reiterates Buy on Encouraging Alixorexton Data and Reduced Oxybate Competition, Lifting Price Target to $57
8d ago
ALKS
Alkermes announces results from planned interim analysis of LTE of alixorexton
PremiumThe Fly
Alkermes announces results from planned interim analysis of LTE of alixorexton
8d ago
ALKS
Alkermes resumed with a Neutral at JPMorgan
PremiumThe Fly
Alkermes resumed with a Neutral at JPMorgan
8d ago
ALKS
Alkermes Ends Generic VIVITROL Supply Agreement with Amneal
PremiumCompany AnnouncementsAlkermes Ends Generic VIVITROL Supply Agreement with Amneal
13d ago
8K
ALKS
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
18d ago
BX
GS
Alkermes price target raised to $65 from $53 at Mizuho
Premium
The Fly
Alkermes price target raised to $65 from $53 at Mizuho
19d ago
ALKS
Adobe downgraded, Roblox upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Adobe downgraded, Roblox upgraded: Wall Street’s top analyst calls
22d ago
U
ON
Alkermes downgraded to Underperform from Neutral at BofA
PremiumThe Fly
Alkermes downgraded to Underperform from Neutral at BofA
22d ago
ALKS
Alkermes price target raised to $65 from $44 at Wells Fargo
PremiumThe Fly
Alkermes price target raised to $65 from $44 at Wells Fargo
22d ago
ALKS
Alkermes price target raised to $61 from $54 at Needham
PremiumThe Fly
Alkermes price target raised to $61 from $54 at Needham
27d ago
ALKS
Alkermes price target raised to $50 from $42 at TD Cowen
PremiumThe FlyAlkermes price target raised to $50 from $42 at TD Cowen
29d ago
ALKS
Alkermes Elevated to $50 Price Target as Orexin Leadership and Alixorexton Pipeline Drive Buy Rating
Premium
Ratings
Alkermes Elevated to $50 Price Target as Orexin Leadership and Alixorexton Pipeline Drive Buy Rating
29d ago
ALKS
Alkermes data support alixorexton in narcolepsy type 2, says H.C. Wainwright
Premium
The Fly
Alkermes data support alixorexton in narcolepsy type 2, says H.C. Wainwright
1M ago
ALKS
Alkermes Price Target Reaffirmed at $43 as Encouraging Vibrance-2 Data Support Neutral Stance
PremiumRatings
Alkermes Price Target Reaffirmed at $43 as Encouraging Vibrance-2 Data Support Neutral Stance
1M ago
ALKS
Closing Bell Movers: Rumble rallies on expansion into AI business
PremiumThe Fly
Closing Bell Movers: Rumble rallies on expansion into AI business
1M ago
NUE
RUM
Alkermes reports ‘positive results’ from Vibrance-2 Phase 2 study of alixorexton
PremiumThe Fly
Alkermes reports ‘positive results’ from Vibrance-2 Phase 2 study of alixorexton
1M ago
ALKS
Alkermes Gains Orphan Status For Sleep Disorder Therapy
PremiumCompany Announcements
Alkermes Gains Orphan Status For Sleep Disorder Therapy
1M ago
8K
ALKS
Alkermes announces ODD for Alixorexton in the U.S., Europe
PremiumThe FlyAlkermes announces ODD for Alixorexton in the U.S., Europe
1M ago
ALKS
Alkermes’ alixorexton granted orphan designation for idiopathic hypersomnia
Premium
The Fly
Alkermes’ alixorexton granted orphan designation for idiopathic hypersomnia
1M ago
ALKS
Alkermes price target raised to $56 from $45 at RBC Capital
Premium
The Fly
Alkermes price target raised to $56 from $45 at RBC Capital
1M ago
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >